More information
Description
The incidence of cancer continues to rise worldwide, therefore, there is an urgent need for the development of novel treatment strategies for cancer patients. Among different cancers in humans, lung cancer is the most common cause of global cancer-related mortality due to late diagnoses and limited treatment interventions. Recent therapeutic strategies such as surgery, radiotherapy, chemo- and immunotherapy are still far to be sufficient for the effective treatment of lung cancer. Therefore, the application of nanotechnology to treat this malignancy unleashes a huge capacity to solve many unmet clinical needs . The project consists of a very ambitious and responsible transnational research and development program in the field of cancer nanotechnology used for personalised nanomedicine. The project integrates different nanoscience resulting in completely new ideas, methods and outputs that will be ready for further exploitation in early clinical trials. The project has a strong pro-industrial potential and will be measured due to defined short- and long-term outcomes. To highlight the long-term impact of project outcomes, the project will address several groups of stakeholders including nanotechnology industry, pharmaceutical industry and regulators. Together Everyone Achieves More (TEAM) is the major transnational idea placed in the project, which merges interdisciplinary team of scientists, medical doctors and business ventures spanning the fields of different medical and biomedical sciences. These collective skills and expertise allow conducting the envisioned transnational studies crossing borders and ideas in cancer nanotechnology.